Baidu
map

J Am Geriat Soc:来看看全世界老年人受虐待的情况

2015-06-16 MedSci MedSci原创

Science Daily:来看看全世界老年人受虐待的情况最新全球调查显示,在社区住宅老年人中,虐待(包括心理,生理,性虐待,忽视老人以及经济剥削)普遍存在。伴有认知障碍和残疾或存在心理疾病的老年人发生虐待的风险更高。北美及南美流行病学研究显示,认知功能完好的老年人中约10%的老人遭受了虐待,而患有老年痴呆症的老人则有47%的老人遭受了虐待。在欧洲,虐待老人的发生率从爱尔兰的2%到克罗地亚的61%


最新全球调查显示,在社区住宅老年人中,虐待(包括心理,生理,性虐待,忽视老人以及经济剥削)普遍存在。伴有认知障碍和残疾或存在心理疾病的老年人发生虐待的风险更高。

北美及南美流行病学研究显示,认知功能完好的老年人中约10%的老人遭受了虐待,而患有老年痴呆症的老人则有47%的老人遭受了虐待。在欧洲,虐待老人的发生率从爱尔兰的2%到克罗地亚的61%不等。在亚洲,中国人虐待老人的发生率最高(36%),发生率最低的为印度(14%)。在非洲,虐待老人的发生率在30%到44%之间。

调查结果表明,卫生专业人员应在临床实践过程中考虑常规筛查老年人受虐待情况,尤其是对于对于受虐高危人群。在审查健康保健人员以管理潜在的虐待事件发生过程中应该提供具体的指导。

美国老年医学会杂志作者Dr. XinQi Dong指出,“由于过早死亡风险,心理疾病的困扰,急诊住院以及养老院使用的增加使得虐待老人以及我们社会无法充分保护最弱小的人群的能力更加恶化。我们需要保护系统、协调且有针对性的研究,教育,宣传以及政策所做的努力,为我们不同社区的黄金人群服务。”

原始出处:

Elder abuse is common around the world. Science Daily.June 15, 2015
       
Xin Qi Dong. Elder Abuse: Systematic Review and Implications for Practice.Journal of the American Geriatrics Society, 2015 DOI: 10.1111/jgs.13454

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2005996, encodeId=481f200599626, content=<a href='/topic/show?id=68d629292b6' target=_blank style='color:#2F92EE;'>#全世界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29292, encryptionId=68d629292b6, topicName=全世界)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKnILSXam1GxPwj04ylEzibYLFA2eGl5Ev02klt80JA0xejMPqrn0mYHNNnLEgyqYTPbicXpY3tn6SA/132, createdBy=38fd2500059, createdName=新生儿张玉军, createdTime=Fri Mar 18 09:22:00 CST 2016, time=2016-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021498, encodeId=1335202149867, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Wed Mar 16 03:22:00 CST 2016, time=2016-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29873, encodeId=fbe9298e3d8, content=善待, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Mon Jun 29 18:00:00 CST 2015, time=2015-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29270, encodeId=c70c292e002, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Thu Jun 25 23:17:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27928, encodeId=664a2e928dd, content=善待老人等于善待自己!, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d031628224, createdName=huangsong808, createdTime=Wed Jun 17 09:45:00 CST 2015, time=2015-06-17, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2005996, encodeId=481f200599626, content=<a href='/topic/show?id=68d629292b6' target=_blank style='color:#2F92EE;'>#全世界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29292, encryptionId=68d629292b6, topicName=全世界)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKnILSXam1GxPwj04ylEzibYLFA2eGl5Ev02klt80JA0xejMPqrn0mYHNNnLEgyqYTPbicXpY3tn6SA/132, createdBy=38fd2500059, createdName=新生儿张玉军, createdTime=Fri Mar 18 09:22:00 CST 2016, time=2016-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021498, encodeId=1335202149867, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Wed Mar 16 03:22:00 CST 2016, time=2016-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29873, encodeId=fbe9298e3d8, content=善待, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Mon Jun 29 18:00:00 CST 2015, time=2015-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29270, encodeId=c70c292e002, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Thu Jun 25 23:17:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27928, encodeId=664a2e928dd, content=善待老人等于善待自己!, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d031628224, createdName=huangsong808, createdTime=Wed Jun 17 09:45:00 CST 2015, time=2015-06-17, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2005996, encodeId=481f200599626, content=<a href='/topic/show?id=68d629292b6' target=_blank style='color:#2F92EE;'>#全世界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29292, encryptionId=68d629292b6, topicName=全世界)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKnILSXam1GxPwj04ylEzibYLFA2eGl5Ev02klt80JA0xejMPqrn0mYHNNnLEgyqYTPbicXpY3tn6SA/132, createdBy=38fd2500059, createdName=新生儿张玉军, createdTime=Fri Mar 18 09:22:00 CST 2016, time=2016-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021498, encodeId=1335202149867, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Wed Mar 16 03:22:00 CST 2016, time=2016-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29873, encodeId=fbe9298e3d8, content=善待, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Mon Jun 29 18:00:00 CST 2015, time=2015-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29270, encodeId=c70c292e002, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Thu Jun 25 23:17:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27928, encodeId=664a2e928dd, content=善待老人等于善待自己!, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d031628224, createdName=huangsong808, createdTime=Wed Jun 17 09:45:00 CST 2015, time=2015-06-17, status=1, ipAttribution=)]
    2015-06-29 owlhealth

    善待

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2005996, encodeId=481f200599626, content=<a href='/topic/show?id=68d629292b6' target=_blank style='color:#2F92EE;'>#全世界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29292, encryptionId=68d629292b6, topicName=全世界)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKnILSXam1GxPwj04ylEzibYLFA2eGl5Ev02klt80JA0xejMPqrn0mYHNNnLEgyqYTPbicXpY3tn6SA/132, createdBy=38fd2500059, createdName=新生儿张玉军, createdTime=Fri Mar 18 09:22:00 CST 2016, time=2016-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021498, encodeId=1335202149867, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Wed Mar 16 03:22:00 CST 2016, time=2016-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29873, encodeId=fbe9298e3d8, content=善待, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Mon Jun 29 18:00:00 CST 2015, time=2015-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29270, encodeId=c70c292e002, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Thu Jun 25 23:17:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27928, encodeId=664a2e928dd, content=善待老人等于善待自己!, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d031628224, createdName=huangsong808, createdTime=Wed Jun 17 09:45:00 CST 2015, time=2015-06-17, status=1, ipAttribution=)]
    2015-06-25 huaxipanxing

    看看

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2005996, encodeId=481f200599626, content=<a href='/topic/show?id=68d629292b6' target=_blank style='color:#2F92EE;'>#全世界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29292, encryptionId=68d629292b6, topicName=全世界)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKnILSXam1GxPwj04ylEzibYLFA2eGl5Ev02klt80JA0xejMPqrn0mYHNNnLEgyqYTPbicXpY3tn6SA/132, createdBy=38fd2500059, createdName=新生儿张玉军, createdTime=Fri Mar 18 09:22:00 CST 2016, time=2016-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021498, encodeId=1335202149867, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Wed Mar 16 03:22:00 CST 2016, time=2016-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29873, encodeId=fbe9298e3d8, content=善待, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Mon Jun 29 18:00:00 CST 2015, time=2015-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29270, encodeId=c70c292e002, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Thu Jun 25 23:17:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27928, encodeId=664a2e928dd, content=善待老人等于善待自己!, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d031628224, createdName=huangsong808, createdTime=Wed Jun 17 09:45:00 CST 2015, time=2015-06-17, status=1, ipAttribution=)]
    2015-06-17 huangsong808

    善待老人等于善待自己!

    0

相关资讯

Europ Urol:老年前列腺癌患者保守治疗效果可观?

新泽西州罗格斯大学癌症研究所以人群为基础的调查研究结果显示,低风险前列腺癌患者接受保守的治疗与管理能够获得良好的生存结果。研究的主要作者、新泽西癌症研究所的流行病学家及Rutgers Robert Wood Johnson医科大学教授Grace Lu-Yao博士,与其同事研究了该观察人群10年的结果 (JAMA,Vol. 302, No. 11)。这一项2009年的研究显示,这群早在1990年患有

J Dent Res:睡觉时佩戴假牙可增加老年人患肺炎的风险

J Dent Res:睡觉时佩戴假牙可增加老年人患肺炎的风险越来越多人意识到不良的口腔卫生是老年人肺炎的主要危险因素。为了确定多种口腔健康相关的危险因素,我们采用了前瞻性研究以评估社区老年人群(年龄在85岁及以上)中一系列的口腔健康行为与肺炎发生率之间可能存在的关系。研究开始随机选择了524名老年人(228名男性和296名女性;平均年龄为87.8岁),检查各研究对象的口腔卫生状况,记录其口腔健康行

质子泵抑制剂可导致肾衰竭?

研究发现,老年患者服用质子泵抑制剂,一种治疗胃灼热和反酸一种常见的药,导致肾衰竭住院率的可能性是未服用者的两倍。虽然副作用是极其罕见的,但是相关性是令人担忧的,因为每年数百万人服用这些处方药和非处方药的销售的药物,包括奥美拉唑,兰索拉唑和奥美拉唑口服混悬液。“一般来说,这些药物耐受性很好,服用这些药物的绝大多数患者不会发展(肾功能衰竭)或其他严重的问题,”研究的首席作者Tony Antoniou,

血脂异常老年人使用他汀类药物中国专家共识发布

为进一步加强我国老年人动脉粥样硬化性心血管病(ASCVD)的防治工作,借鉴今年发布的国际血脂管理指南和临床证据,近日,我国部分老年心脑血管病专家更新了2010年版《血脂异常老年人使用他汀类药物中国专家共识》。(中华内科杂志.2015,54:467) 共识指出,他汀类药物治疗可降低ASCVD的病死率,减少心血管事件。由于老年人心血管病患病率高,发生心血管事件的危险更大,他汀类药物治疗带来的

老年人他汀应用中国共识:避免盲目应用大剂量

人老了,相对就脆弱了,有临床医生对老年人使用他汀药物的安全有效性有一种担忧。看看由胡大一、赵水平等专家组成的血脂异常老年人使用他汀类药物中国专家共识组制定的共识怎么说。  老年人血脂异常特点  流行病学调查结果显示,随着年龄增加,总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)和甘油三酯(TG)水平也逐渐增加。  与欧美国家相比,我国老年人的TC、LDL-C和TG平均水平均低于西方人群,以轻、中

BMJ:降脂治疗可减少老年人卒中发生率达30%

法国学者在无已知血管事件的老年人中研究了降脂药物(他汀或贝特类)与冠心病和卒中长期风险的关系,结果表明,他汀或贝特类药物可减少上述人群30%的卒中发生率。相关论文5月19日在线发表于《英国医学杂志》(简称BMJ)杂志。研究者们随机纳入了居住在法国3个城市社区人群7484例,年龄≥65岁(平均年龄73.9岁),女性占63%,入组时受试者均无无已知血管事

Baidu
map
Baidu
map
Baidu
map